This session is designed to provide an overview of key safety reporting obligations associated with marketed medicinal products. Several exercises will be included.

Have an account?

Pragmatic Approaches to Drug Safety Across the Premarketing and Postmarketing Continuum

Session 22: Postmarketing Safety Principles and Spontaneous Case Reporting

Session Chair(s)

JP Clement, MD

Be informed and stay engaged.